Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer - United States
doi 10.1002/cncr.25071
Full Text
Open PDFAbstract
Available in full text
Date
April 7, 2010
Authors
Publisher
Wiley